Theravance Biopharma, Inc. ( TBPH) - Stock Earnings
TBPH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 3.6 million USD | 20.0 million USD |
| 2025Q4 | 61.0 million USD | 45.9 million USD |
| 2026Q1 | -4.9 million USD | 17.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TBPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -55.2 million USD | 57.4 million USD |
| 2024 | -56.4 million USD | 64.4 million USD |
| 2025 | 105.9 million USD | 107.5 million USD |
| 2026 Est. | — | — |
TBPH
Price: $16.29
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.23 USD
P/E Ratio: 7.41
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Cayman Islands
Volume: 260600
Ebitda: -62.9 millionMarket Capitalization: 803.2 million